rxstat › Drug prices › group 0162417

group 0162417 (Ruzurgi) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

group 0162417 10 mg tablet costs about $18.00 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.

group 0162417 has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formABSKNBNS
10 mg Tabletper tablet$18.00$18.00$18.00$18.00
Plan coverageCoveredSpecial approvalSpecial approvalSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 2 products
  • Firdapse 10 mg Tablet · KYE
    DIN 02502984 · $18.00/tablet · Covered
  • Ruzurgi 10 mg Tablet · MDK
    DIN 02503034 · $20.00/tablet · Covered
Saskatchewan: 2 products
  • Firdapse 10 mg Tablet · KYE
    DIN 02502984 · $18.00/tablet · Special approval
  • Ruzurgi 10 mg Tablet · MEC
    DIN 02503034 · $20.00/tablet · Special approval
New Brunswick: 2 products
  • Firdapse 10 mg Tablet · KYE
    DIN 02502984 · $18.00/tablet · Special approval
  • Ruzurgi 10 mg Tablet · MDU
    DIN 02503034 · $20.00/tablet · Special approval
Nova Scotia: 2 products
  • Firdapse 10 mg Tablet · KYE
    DIN 02502984 · $18.00/tablet · Special approval
  • Ruzurgi 10 mg Tablet · MDU
    DIN 02503034 · $20.00/tablet · Special approval

Price sources: Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
2

Reports by product

The DIN is printed on your prescription label.

reversed
RUZURGI
10MG · TABLET · MEDUNIK CANADA
DIN 02503034
Resolved
RUZURGI
10MG · TABLET · MEDUNIK CANADA
DIN 02503034 · ended Jun 24, 2021 · Review post JR resolved

What's happening

There are no active shortage reports for group 0162417. Health Canada has 2 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Recent changes

Common questions

How much does group 0162417 cost in Canada?

group 0162417 10 mg tablet costs about $18.00 per tablet on public drug plan price lists across 4 provinces, before the pharmacy's dispensing fee.

Is group 0162417 covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will group 0162417 be back in stock in Canada?

group 0162417 has no active shortage; supply is normal per Health Canada reports.

Why is group 0162417 in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.